// App-Quantinova.ai

: Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR

Researchers

Presenter

  • Andrew Menzies-Gow

Principal Investigators

  • Jonathan Corren

  • Elliot Israel

  • Tobias Welte

  • Christopher S Ambrose

  • Bill Cook

  • Gillian Hunter

  • Jean-Pierre Llanos-Ackert

  • Gene Colice

Medical Centers

  • Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States of America

  • The Royal Marsden Hospital, London, United Kingdom

  • Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, United States of America

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

  • Department of Respiratory Medicine and the German Center for Lung Research, Hannover Medical School, Hannover, Germany.

Locations

  • United States

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Asthma

  • Spastic paraplegia, intellectual disability, nystagmus, and obesity

Biomarkers

  • N/A

Drug/Treatment

  • Tezepelumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • III

Study Id's

  • NCT03347279

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved